SEC Form 4 · accession 0001209191-18-021781
Horizon Pharma plc · HZNP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert Carey
Officer — EVP, Chief Business Officer
Period of report
Mar 23, 2018
Accepted (ET)
Mar 27, 2018 · 5:29 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001492426
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Mar 23, 2018 | M | 31,000 | — | A | 48,189 | D | |
| Ordinary Shares | Mar 23, 2018 | F | 9,083 | $13.86 | D | 39,106 | D | |
| Ordinary Shares | holding | — | — | — | 131,028 | I | By Robert F. Carey III Trust dated 4/24/2001 |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | — | Mar 23, 2018 | M | 31,000 | D | — | — | Ordinary Shares | 31,000 | 31,000 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer.
- F2On March 23, 2015, the reporting person was granted 124,000 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.